Tuesday, February 17, 2026

North Korea Modernizes Long-Range Launch Vehicle Engine Testing Site… Continues Development of New Solid-Fuel Engine

North Korea upgrades its engine test stand, enhancing missile development efficiency with a new foldable cover design for better operations.

Constitutional Court Rules Against Yoon, South Korea’s Second Ousted President

President Yoon Suk Yeol is impeached by the Constitutional Court, marking a significant event in South Korea’s political history.

THE GREAT WALL CRACKS: TikTok Admits Defeat, Handing Over Control To Washington Insiders

TikTok hires lobbyist Ziad Ojakli as it navigates U.S. operations sale amid security concerns, with ByteDance proposing algorithm licensing.

Jung Eun Kim

Author's Latest

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Wontek’s V-Laser Approved for Versatile Treatments in Vietnam: A Game-Changer for Aesthetic Clinics

Wontech secures medical device approval for its V-Laser in Vietnam, enhancing its product lineup and market presence in medical aesthetics.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

Why Centrum Multivitamins Are Backed by 32 Clinical Studies: A Deep Dive into Their Proven Benefits

Centrum multivitamins stand out for their extensive research backing, showing benefits in cancer risk reduction and cognitive function.

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

HM15275 Clinical Trials: What You Need to Know About This Groundbreaking Obesity Treatment

Hanmi Pharmaceutical's HM15275 enters Phase 2 trial, aiming to revolutionize obesity treatment and diabetes management by 2030.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Pneumonia Death Rates in South Korea: Why Vaccination is Crucial for High-Risk Groups

Pneumonia is South Korea's third leading cause of death; prevention is crucial, especially for high-risk groups after influenza.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

How Celltrion is Tackling U.S. Tariff Risks with New Production Facility in 2026

Celltrion addresses tariff risks by acquiring a U.S. facility, ensuring product supply and implementing strategies to mitigate uncertainties.

Why a High-Concentration Albumin Product Is Expanding Nationwide After 13 Straight Sellouts

Daewon Pharmaceutical expands offline distribution of Albumin King to major department stores across Korea, boosting consumer access and sales.

Revolutionary mRNA Cancer Treatment Shows 49% Survival Improvement: What You Need to Know

A study shows mRNA-based cancer treatments significantly improve survival rates, marking a breakthrough in precision therapy for melanoma.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.